Apellis Pharmaceuticals, Inc. (BIT:1APLS)
Italy · Delayed Price · Currency is EUR 18.71
-1.14 (-5.72%)
At close: Feb 11, 2026
Apellis Pharmaceuticals Market Cap
Apellis Pharmaceuticals has a market cap or net worth of €2.4 billion as of February 11, 2026. Its market cap has decreased by -31.26% in one year.
Market Cap
2.40B
Enterprise Value
2.40B
Revenue
866.28M
Ranking
n/a
PE Ratio
62.61
Stock Price
€18.71
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from 593.77M to 2.40B, an increase of 304.31%. That is a compound annual growth rate of 18.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 2.38B | -12.11% |
| Dec 31, 2025 | 2.71B | -29.40% |
| Dec 31, 2024 | 3.83B | -40.26% |
| Dec 29, 2023 | 6.42B | 19.95% |
| Dec 30, 2022 | 5.35B | 32.19% |
| Dec 31, 2021 | 4.05B | 14.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Webuild | 3.55B |
| Brembo | 3.40B |
| ERG S.p.A. | 3.36B |
| Amplifon | 3.11B |
| Cementir Holding | 2.96B |
| ENAV S.p.A. | 2.70B |
| MFE-Mediaforeurope | 2.41B |
| Carel Industries | 2.36B |